This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
With a bevy of blockbuster drugs slated to lose patent protection over the next several years and a number of large pharmaceutical players cutting staff, life science instrument vendors could be facing a potential tightening of pharma spending budgets reminiscent of a couple of years ago.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.